ArticleBlood and lymphatic cancer : targets and therapy2026
Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study.
Chen Qiu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.